Clinical Trial Update: Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemotherapy combined with finotonlimab for locally advanced hypopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Carcinoma

Drugs mentioned

• Finotonlimab

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Hypopharyngeal Carcinoma | Phase 2 | Status: RECRUITING